CHINA BCT PHARMACY GROUP, INC. Selling Expense
CHINA BCT PHARMACY GROUP, INC. reported Selling Expense of $2.39 million for the 3-month period ending 2013-03-31, per its 10-Q filed 2013-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2013-05-20
- CHINA BCT PHARMACY GROUP, INC. selling expense for the quarter ending 2013-03-31 was $2.39M, a 0.51% increase year-over-year.
- CHINA BCT PHARMACY GROUP, INC. selling expense for the quarter ending 2012-12-31 was $670.28K, a 62.24% decline year-over-year.
- CHINA BCT PHARMACY GROUP, INC. selling expense for the quarter ending 2012-09-30 was $2.36M, a 37.01% increase year-over-year.
- CHINA BCT PHARMACY GROUP, INC. selling expense for the quarter ending 2012-06-30 was $2.18M, a 23.22% increase year-over-year.
- CHINA BCT PHARMACY GROUP, INC. selling expense for fiscal 2012 was $7.59M, a 5.26% increase from fiscal 2011.
- CHINA BCT PHARMACY GROUP, INC. selling expense for fiscal 2011 was $7.21M, a 34.77% increase from fiscal 2010.
- CHINA BCT PHARMACY GROUP, INC. selling expense for fiscal 2010 was $5.35M.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2013-03-31 | $2.39M 10-Q · filed 2013-05-20 | $3.06M derived: sum of 2 quarters · filed 2013-05-20 | $5.42M derived: sum of 3 quarters · filed 2013-05-20 | $7.60M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-12-31 | $670.28K derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $3.03M derived: sum of 2 quarters · filed 2013-04-15 | $5.21M derived: sum of 3 quarters · filed 2013-04-15 | $7.59M 10-K · filed 2013-04-15 |
| 2012-09-30 | $2.36M 10-Q · filed 2012-11-15 | $4.54M derived: sum of 2 quarters · filed 2012-11-15 | $6.92M 10-Q · filed 2012-11-15 | $8.69M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-06-30 | $2.18M 10-Q · filed 2012-08-17 | $4.56M 10-Q · filed 2012-08-17 | $6.34M derived: sum of 3 quarters · filed 2013-05-20 | $8.06M derived: sum of 4 quarters · filed 2013-05-20 |
| 2012-03-31 | $2.38M 10-Q · filed 2013-05-20 | $4.16M derived: sum of 2 quarters · filed 2013-05-20 | $5.88M derived: sum of 3 quarters · filed 2013-05-20 | $7.65M derived: sum of 4 quarters · filed 2013-05-20 |
| 2011-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15 | $3.50M derived: sum of 2 quarters · filed 2013-04-15 | $5.27M derived: sum of 3 quarters · filed 2013-04-15 | $7.21M 10-K · filed 2013-04-15 |
| 2011-09-30 | $1.72M 10-Q · filed 2012-11-15 | $3.49M derived: sum of 2 quarters · filed 2012-11-15 | $5.44M 10-Q · filed 2012-11-15 | $7.31M derived: sum of 4 quarters · filed 2012-11-15 |
| 2011-06-30 | $1.77M 10-Q · filed 2012-08-17 | $3.72M 10-Q · filed 2012-08-17 | $5.59M derived: sum of 3 quarters · filed 2012-08-17 | $6.98M derived: sum of 4 quarters · filed 2012-08-17 |
| 2011-03-31 | $1.94M 10-Q · filed 2012-05-21 | $3.82M derived: sum of 2 quarters · filed 2012-06-12 | $5.21M derived: sum of 3 quarters · filed 2012-06-12 | $6.27M derived: sum of 4 quarters · filed 2012-06-12 |
| 2010-12-31 | $1.88M derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-06-12 | $3.26M derived: sum of 2 quarters · filed 2012-06-12 | $4.32M derived: sum of 3 quarters · filed 2012-06-12 | $5.35M 10-K/A · filed 2012-06-12 |
| 2010-09-30 | $1.38M 10-Q · filed 2011-11-14 | $2.44M derived: sum of 2 quarters · filed 2011-11-14 | $3.47M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $1.06M 10-Q · filed 2011-08-15 | $2.09M 10-Q · filed 2011-08-15 |